Investment Rating - The report assigns an "Add" rating for the company, indicating a positive outlook for investment [5]. Core Views - The company is recognized as a leading low-cost coal producer in Australia, with a strong focus on high-quality thermal coal products primarily exported to the Asia-Pacific region [4]. - The company is expected to experience a rebound in both volume and price in 2026, following a decrease in volume and price in 2025, with a notable increase in profitability anticipated due to rising coal prices [4][5]. - The company maintains a low debt level, supporting high dividend payouts, with a commitment to distribute 50% of net profit or free cash flow, whichever is higher [4]. Summary by Relevant Sections Company Overview - The company operates eight coal mines, producing approximately 70 million tons of raw coal and 55 million tons of saleable coal annually, with a significant portion of sales directed towards China, Japan, South Korea, and Taiwan [4]. Financial Performance - For 2025, the company expects a revenue of AUD 595 million and a net profit of AUD 44 million, reflecting a year-on-year decline of 13.3% and 63.8%, respectively [4][6]. - The average selling price for coal in 2025 is projected to be AUD 146 per ton, down 17% from the previous year, with a significant market premium for high-quality thermal and metallurgical coal [4]. Profitability Forecast - The company forecasts net profits of AUD 867 million, AUD 1.31 billion, and AUD 1.78 billion for 2026, 2027, and 2028, respectively, with a corresponding PE ratio of 7.68 for 2026 [6]. - The report highlights a strong potential for profit growth, with expected increases in both revenue and net profit in the coming years [5][6]. Market Position - The company benefits from a favorable market position due to its cost advantages and high-quality coal products, which are expected to command premium prices in the market [4][5].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Insights - The company reported a strong Q4 performance with revenue of 8.32 billion yuan (up 8% YoY and QoQ) and a net profit of 513 million yuan (up 471% YoY and 9% QoQ) [4] - The growth in revenue is driven by increased value-added services and advertising revenue, with advertising income rising by 27% YoY [4] - The company plans to enhance its AI investments, leading to revised net profit forecasts for 2026-2028 [4] Financial Summary - Revenue projections for 2024A to 2028E are as follows: 26.83 billion, 30.35 billion, 33.31 billion, 36.19 billion, and 38.52 billion yuan respectively, with YoY growth rates decreasing from 19.1% to 6.4% [5] - Net profit is expected to improve significantly from a loss of 1.35 billion yuan in 2024A to a profit of 3.31 billion yuan in 2028E [5] - The gross margin is projected to increase from 32.7% in 2024A to 40.2% in 2028E, indicating improved operational efficiency [5]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Insights - The company reported a strong Q4 performance with revenue of 8.32 billion yuan (up 8% YoY and QoQ) and a net profit of 513 million yuan (up 471% YoY and 9% QoQ) [4] - The growth in revenue is driven by increased advertising revenue, which rose to 3.04 billion yuan (up 27% YoY and 18% QoQ), and value-added services revenue of 3.26 billion yuan (up 6% YoY and 8% QoQ) [4] - The company plans to increase investment in AI, leading to revised net profit forecasts for 2026-2028 [4] Financial Summary and Valuation Metrics - Revenue projections for the upcoming years are as follows: 2024A: 26.83 billion yuan, 2025A: 30.35 billion yuan, 2026E: 33.31 billion yuan, 2027E: 36.19 billion yuan, 2028E: 38.52 billion yuan [5] - Net profit projections are: 2024A: -1.35 billion yuan, 2025A: 1.19 billion yuan, 2026E: 1.57 billion yuan, 2027E: 2.49 billion yuan, 2028E: 3.31 billion yuan [5] - The company’s P/E ratios are projected to be 46.7 for 2026, 29.5 for 2027, and 22.2 for 2028 [5]

Investment Rating - The report assigns an "Add" rating for the company, marking its first coverage [5]. Core Views - The company is recognized as a leading low-cost coal producer in Australia, with high-quality thermal coal products primarily exported to the Asia-Pacific region [4]. - The company is expected to experience a rebound in both volume and price in 2026, following a decrease in volume and price in 2025, with a strong market elasticity for its products [4]. - The company has a solid balance sheet with low debt, supporting high dividend payouts, and its valuation presents a safety margin [4]. Summary by Relevant Sections Company Overview - The company operates eight coal mines, producing approximately 70 million tons of raw coal and 55 million tons of saleable coal annually, with a significant portion of its sales directed towards China, Japan, South Korea, and Taiwan [4]. - In 2025, the company’s sales volume of thermal coal accounted for 84% of its total sales, with a historical high of 38.6 million tons sold [4]. Financial Performance - For 2025, the company reported a revenue of AUD 594.9 million and a net profit of AUD 44 million, reflecting a year-on-year decline of 13.3% and 63.8%, respectively [4][6]. - The average selling price for 2025 was AUD 146 per ton, down 17% from the previous year, with expectations of price recovery in 2026 [4]. Profitability Forecast - The company’s net profit is projected to rebound significantly in the coming years, with estimates of AUD 866 million in 2026, AUD 1.312 billion in 2027, and AUD 1.775 billion in 2028 [6]. - The projected P/E ratio for 2026 is 7.68, indicating a favorable valuation compared to historical performance [6].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company's performance in 2025 slightly exceeded previous expectations, with total revenue of HKD 14.58 billion, a year-on-year increase of 11.5%, and a net profit attributable to shareholders of HKD 980.29 million, up 14.82% year-on-year [7] - The company is expected to continue improving its profit margins, with a projected gross margin of 10.43% in 2026, up from 10.1% in 2025 [7] - The company is positioned as the only publicly listed entity under China Tobacco International, focusing on the export of tobacco products and expanding its global footprint [7] Financial Projections - Total revenue projections for the company are as follows: - 2024: HKD 13.07 billion - 2025: HKD 14.58 billion - 2026: HKD 15.77 billion - 2027: HKD 17.16 billion - 2028: HKD 18.54 billion - The net profit attributable to shareholders is projected to be: - 2024: HKD 853.74 million - 2025: HKD 980.29 million - 2026: HKD 1.10 billion - 2027: HKD 1.34 billion - 2028: HKD 1.56 billion [1][8] - The earnings per share (EPS) forecast is as follows: - 2024: HKD 1.23 - 2025: HKD 1.42 - 2026: HKD 1.59 - 2027: HKD 1.94 - 2028: HKD 2.26 [1][8] Business Segmentation - Revenue from different business segments in 2025 includes: - Tobacco leaf imports: HKD 9.54 billion (up 16% year-on-year) - Tobacco leaf exports: HKD 2.48 billion (up 20% year-on-year) - Cigarette exports: HKD 1.67 billion (up 6% year-on-year) - New tobacco products: HKD 0.06 billion (down 52% year-on-year) - Brazilian operations: HKD 0.83 billion (down 21% year-on-year) [7] - The company plans to optimize its supply chain, which is expected to enhance the gross margin of its cigarette export business [7]

Investment Rating - The report maintains a "Buy" rating for the company with a target price of HKD 18.78 [6][15] Core Insights - The company reported a total revenue of RMB 13.7 billion for 2H25, representing a year-on-year increase of 16.3%, which exceeded Bloomberg's expectation of RMB 13.5 billion. The adjusted net profit was RMB 610 million, up 7.0% year-on-year, also surpassing expectations [1][2] - The company has been included in the Hong Kong Stock Connect list, effective from March 9, which is expected to enhance shareholder structure and improve liquidity [1] - The company is focusing on expanding its core user base and market share through technology-driven efficiency improvements and group synergies, particularly in the areas of enterprise digital procurement and cost reduction [1] Revenue and Profitability - In 2H25, the company's GMV reached RMB 18.9 billion, a 16% increase year-on-year, with key enterprise customer GMV growing by 24% to RMB 9.7 billion [2][12] - The gross margin for 2H25 improved to 16.5%, an increase of 0.7 percentage points year-on-year, primarily due to upstream channel enhancements and increased sales of warehouse goods [2] - The total operating expense ratio for 2H25 was 13.4%, up 2.0 percentage points year-on-year, driven by increased fulfillment costs and investments in BOM and overseas business expansion [2] Customer Base and Supply Chain - The company served 13,300 key enterprise customers in 2025, a 26% increase from the previous year, with a retention rate of 116.6% [3] - The number of manufacturers, distributors, and agents connected by the company reached 205,000 in 2025, up from 158,000 in the previous year [3] Technological Advancements - The company launched the industry's first AI-native product and material governance center, significantly reducing the time required for material governance tasks [4] - The company is developing its own brand to ensure quality and streamline supply for non-standard and dispersed products [4] Financial Forecasts - The adjusted net profit forecasts for 2026 and 2027 have been slightly increased to RMB 1.59 billion and RMB 2.17 billion, respectively, due to better-than-expected revenue growth and expense management [5][12] - The report anticipates a revenue CAGR of 20.0% from 2025 to 2027, compared to 9.9% for comparable companies, indicating a strong growth outlook for the company [15][17]

Investment Rating - The report maintains a "Hold" rating for the company [7] Core Insights - The company reported a total revenue of HKD 28.17 billion for the year 2025, a decrease of 2.1% year-on-year, with adjusted EBITDA of HKD 3.20 billion, down 15.0% year-on-year [1] - The fourth quarter of 2025 saw total revenue of HKD 6.50 billion, a decline of 13.0% year-on-year and 7.6% quarter-on-quarter, with adjusted EBITDA of HKD 670 million, down 32.4% year-on-year [1][2] - The company is undergoing a structural transition due to the closure of satellite gaming venues, which has impacted its gross gaming revenue (GGR) recovery [3][4] Summary by Sections Financial Performance - For Q4 2025, GGR was HKD 6.66 billion, down 11.6% year-on-year and 6.8% quarter-on-quarter, recovering to 66% of Q4 2019 levels [2] - The VIP segment generated HKD 590 million, down 19.6% year-on-year, while the mass market segment generated HKD 5.46 billion, down 11.5% year-on-year [2] - The company reported a loss of HKD 28 million for the EBITDA of the Grand Lisboa, with an EBITDA margin of -3.3% [2] Strategic Developments - The company has completed strategic acquisitions in the core area of the peninsula, including a HKD 529 million acquisition of a designated area in the Lisboa Hotel and a HKD 1.75 billion acquisition of the property at the Parisian Macao [3] - The transition period is expected to stabilize as the company reallocates resources and optimizes operations [4] Profit Forecast and Valuation - The EBITDA forecast for 2026 and 2027 has been revised down to HKD 4.073 billion and HKD 4.320 billion, respectively, reflecting a decrease of 12% and 10% from previous estimates [5][13] - The target price has been adjusted to HKD 2.54, corresponding to a 12x EV/EBITDA multiple for 2026 [5][14]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company's performance in 2025 slightly exceeded previous expectations, with total revenue reaching HKD 14.58 billion, a year-on-year increase of 11.5%. The gross profit was HKD 1.47 billion, up 7% year-on-year, and the net profit attributable to shareholders was HKD 980.29 million, reflecting a year-on-year growth of 15% [7] - The company is expected to continue improving its profit margins, with a projected gross margin of 10.1% for 2025, slightly down by 0.4 percentage points year-on-year. The gross margins for various business segments are expected to improve due to better pricing strategies and increased scale [7] - The company is positioned as the only publicly listed entity under China Tobacco International, focusing on the export of tobacco products and expanding its global footprint, which is anticipated to drive further growth [7] Financial Summary - Total revenue projections for the company are as follows: HKD 13.07 billion in 2024, HKD 14.58 billion in 2025, HKD 15.77 billion in 2026, HKD 17.16 billion in 2027, and HKD 18.54 billion in 2028, with respective year-on-year growth rates of 10.46%, 11.51%, 8.19%, 8.77%, and 8.07% [1] - The net profit attributable to shareholders is projected to be HKD 853.74 million in 2024, HKD 980.29 million in 2025, HKD 1.10 billion in 2026, HKD 1.34 billion in 2027, and HKD 1.56 billion in 2028, with year-on-year growth rates of 42.58%, 14.82%, 12.08%, 22.38%, and 16.33% respectively [1] - The earnings per share (EPS) are expected to be HKD 1.23 in 2024, HKD 1.42 in 2025, HKD 1.59 in 2026, HKD 1.94 in 2027, and HKD 2.26 in 2028, with a corresponding price-to-earnings (P/E) ratio decreasing from 30.71 in 2024 to 16.76 in 2028 [1]

Investment Rating - The investment rating for the company is "Buy" (maintained) [5] Core Views - The company is expected to achieve steady revenue growth for the full year, with the designer series enhancing the main brand's momentum [5] - The high sales period for FY2026 is coming to an end, but the company is projected to achieve mid-single-digit revenue growth for the full year [8] - The main brand's down jacket business is expected to grow steadily, with a projected revenue increase slightly above the overall group growth rate [8] Financial Forecasts and Valuation - Revenue projections (in million RMB) for the upcoming years are as follows: - 2024: 23,214.03 - 2025: 25,901.71 (growth rate: 38.39%) - 2026E: 27,140.42 (growth rate: 4.78%) - 2027E: 28,915.83 (growth rate: 6.54%) - 2028E: 31,014.57 (growth rate: 7.26%) [7] - Net profit projections (in million RMB) are as follows: - 2024: 3,074.07 - 2025: 3,513.91 (growth rate: 43.74%) - 2026E: 3,725.23 (growth rate: 6.01%) - 2027E: 3,993.65 (growth rate: 7.21%) - 2028E: 4,308.95 (growth rate: 7.90%) [7] - The company maintains a high dividend payout intention, supported by strong brand image and product development capabilities [8]

Investment Rating - The report maintains a "Buy" rating for JD Health [3][8]. Core Insights - JD Health achieved a revenue of 73.44 billion RMB in 2025, representing a year-on-year growth of 26.3%. The company's product revenue grew by 24.8% to 60.88 billion RMB, while service revenue increased by 34.1% to 12.56 billion RMB [8]. - The gross margin improved by 1.9 percentage points to 24.8%, driven by a higher proportion of high-margin service revenue and optimization of product structure [8]. - The annual profit reached 5.37 billion RMB, a 29.1% increase year-on-year, with Non-IFRS net profit hitting 6.53 billion RMB, up 36.3%, marking a historical high [8]. - The number of active users increased to 218 million, a net addition of 34.1 million from the previous year [8]. - The company launched over 100 new drugs in 2025, significantly up from more than 30 in 2024, reinforcing its position as a leader in new drug launches [8]. - The service revenue growth was fueled by an increase in the number of platform advertisers, leading to a rise in digital marketing service fees [8]. - JD Health's AI-enabled services and expansion of offline stores contributed to a comprehensive health service model, integrating online and offline operations [8]. - The report forecasts revenue growth for 2026-2028 at 85.57 billion RMB, 97.99 billion RMB, and 108.05 billion RMB, respectively, with adjusted net profits of 6.6 billion RMB, 7.6 billion RMB, and 8.4 billion RMB [8]. Financial Metrics Summary - Revenue for 2025 is projected at 73.44 billion RMB, with a growth rate of 26.3% [2]. - Adjusted net profit for 2025 is estimated at 6.53 billion RMB, reflecting a growth rate of 36% [2]. - The earnings per share (EPS) based on adjusted net profit is expected to be 2.03 RMB for 2025, with a price-to-earnings (P/E) ratio of 21 [2]. - The price-to-book (P/B) ratio is projected to be 2.3 for 2025 [2].